PE Ratio

Is the price-earnings ratio for valuing a company that measures its current share price relative to its earnings per share.

P/E RATIO
EPS

The earnings per share ratio is a portion of company's net profit allocated for each outstanding share. It is calculated by deducting preferred stock divided from the net income of the company divided by the number of outstanding shares.

EPS
PRICE/BOOK

Price-to-book ratio is used to compared the company's current market price with its book value.

PRICE/BOOK
Deliverable

These are the acutal number of shares that are traded on delivery based, meaning transfered from one person to another during the day's trade.

DELIVERABLES
DIV YIELD.(%)

Dividend Yield measures the quantum of cash dividends paid to shareholders in a financial year relative to the market value of the per share.

DIV YIELD.(%)

Company Details

Check out the key parameters of the company to understand the financial health and stock performance

Key Level

Resistance 1
-
Resistance 2
-
Support 1
-
Support 2
-

Moving Average

20 Days
-
50 Days
-
100 Days
-
200 Days
-
Growth in 3 years

Sales


Sales Industry Avg


PAT


PAT Industry Avg


Growth in 3 years

Total Asset Growth
26.45%

Total Liabilities growth
9.50%

Reserves Change
-6.41%



Relative to Sensex rtn in 3 year


Relative to Nifty rtn in 3 year


Relative to top 3 MF rtn in 3 year


2016 2014 2014
Sales 59.91 59.91 59.91
Gross Profit 60.14 60.14 60.14
Operating Profit 6.14 6.14 6.14
Sales 59.91 59.91 59.91
Gross Profit 60.14 60.14 60.14
Operating Profit 6.14 6.14 6.14

Peer Companies

A quick glance on how stocks from the same sector have performed along with some key parameters

View More

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

 

If I had made
investment of  
in
Months Ago
My investment would be worth with a of %

Our Research Reports

Stocks and sector-wise Research Reports by HDFC securities help you analyse, understand and take a informed investment decision.

View More

Corporate Action

Find out the historical dividend payout and other corporate actions including bonus, stock split and rights issue etc.

FnO

A snapshot on how the stock has performed in the derivatives segment on a real-time basis.

View More

MF Holdings

Here's a list of major funds which hold the stock in their portfolio as of the last reported quarter.

Scheme Name AUM (%) CMV ( in Cr.) Holding Date
Aditya Birla Nuvo Ltd 35.67 35.67 35.67
Aditya Birla Nuvo Ltd 35.67 35.67 35.67
Aditya Birla Nuvo Ltd 35.67 35.67 35.67
Aditya Birla Nuvo Ltd 35.67 35.67 35.67
Aditya Birla Nuvo Ltd 35.67 35.67 35.67
View More

News

Stay tuned to the latest developments and happenings in the company.

Marksans Pharma consolidated net profit rises 31.27% in the December 2023 quarter

Net profit of Marksans Pharma rose 31.27% to Rs 83.24 crore in the quarter ended December 2023 as against Rs 63.41 crore during the previous quarter e....

13 Feb 2024 16:31

Marksans Pharma to declare Quarterly Result

Marksans Pharma will hold a meeting of the Board of Directors of the Company on 13 February 2024.Powered by Capital Market - Live News</b....

17 Jan 2024 17:29

Marksans Pharma receives upgrade in credit ratings

Marksans Pharma has received upgrade in credit ratings for bank facilities from India Ratings and Research as under:Fund based limits (Rs 100 crore....

08 Dec 2023 16:03

Marksans Pharma consolidated net profit rises 36.36% in the September 2023 quarter

Net profit of Marksans Pharma rose 36.36% to Rs 83.52 crore in the quarter ended September 2023 as against Rs 61.25 crore during the previous quarter ....

09 Nov 2023 15:15

Marksans Pharma standalone net profit declines 22.22% in the September 2023 quarter

Net profit of Marksans Pharma declined 22.22% to Rs 31.29 crore in the quarter ended September 2023 as against Rs 40.23 crore during the previous quar....

09 Nov 2023 14:28

Marksans arm receives UK MHRA marketing authorisation for Cyanocobalamin 50mg film coated tablet

Marksans Pharma announced that its wholly owned subsidiary Relonchemhas received Marketing Authorisation for the product Cyanocobalamin 50mg film coat....

06 Nov 2023 18:30

View More
Subscribe for our
newsletter
Open Account Now